Condition
Hereditary Angioedema Type I and II
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Unknown1
Enrolling By Invitation1
Clinical Trials (2)
Showing 2 of 2 trials
NCT05396105Phase 2Enrolling By Invitation
Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema
NCT03828279UnknownPrimary
Global Registry to Gather Data on Natural History of Patients With Hereditary Angioedema Type I and II
Showing all 2 trials